Two Cases of Severe Lung Complication Associated with GVHD after Stem Cell Transplantation from the Non-Inherited Maternal Antigen (NIMA) -Mismatched Sibling Donor

In the selection of alternative donors for stem cell transplantation (SCT), if an HLA full-match donor can not be secured, the identity of the most appropriate donor is unclear. We experienced two children with refractory, acute myeloblastic leukemia (AML) who underwent SCT from the non-inherited ma...

Full description

Saved in:
Bibliographic Details
Published inThe Japanese Journal of Pediatric Hematology Vol. 22; no. 1; pp. 21 - 27
Main Authors GOTO, Hiroaki, YOKOTA, Shumpei, YOKOSUKA, Tomoko, YANAGIMACHI, Masakatsu, FUJII, Hisaki, TAKAHASHI, Hiroyuki, KUROKI, Fumiko, MINAI, Amane
Format Journal Article
LanguageJapanese
Published THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY 2008
特定非営利活動法人 日本小児血液・がん学会
Subjects
Online AccessGet full text
ISSN0913-8706
1884-4723
DOI10.11412/jjph1987.22.21

Cover

Abstract In the selection of alternative donors for stem cell transplantation (SCT), if an HLA full-match donor can not be secured, the identity of the most appropriate donor is unclear. We experienced two children with refractory, acute myeloblastic leukemia (AML) who underwent SCT from the non-inherited maternal antigen (NIMA) -mismatched sibling donor linked with long-term feto-maternal microchimerism, with expectation of graft-versusleukemia (GVL) effect. The engraftments were speedy and acute graft-versus-host disease (GVHD) did not occur. But after donor lymphocyte infusion (DLI) or acute tapering of their immunosuppressant, severe lung complication with GVHD occurred in both cases. Our cases suggest the risk of immunotherapy after SCT from a NIMA-mismatched sibling donor.
AbstractList In the selection of alternative donors for stem cell transplantation (SCT), if an HLA full-match donor can not be secured, the identity of the most appropriate donor is unclear. We experienced two children with refractory, acute myeloblastic leukemia (AML) who underwent SCT from the non-inherited maternal antigen (NIMA) -mismatched sibling donor linked with long-term feto-maternal microchimerism, with expectation of graft-versusleukemia (GVL) effect. The engraftments were speedy and acute graft-versus-host disease (GVHD) did not occur. But after donor lymphocyte infusion (DLI) or acute tapering of their immunosuppressant, severe lung complication with GVHD occurred in both cases. Our cases suggest the risk of immunotherapy after SCT from a NIMA-mismatched sibling donor. 造血幹細胞移植 (SCT) が必要な症例においてHLA一致骨髄ドナーが得られない場合, 代替ドナーの選択基準は必ずしも明らかではない.当科では移植片対白血病 (GVL) 効果誘導を期待して, HLA一致骨髄ドナーが得られなかった2例の小児再発急性骨髄性白血病患者に対し, 母子間マイクロキメリズム陽性を確認したnon-inherited maternal antigen (NIMA) 相補的同胞からのSCTを施行した.いずれの症例でも速やかな生着が得られ, 初期には重症移植片対宿主病 (GVHD) の発症はみられなかったが, ドナーリンパ球輸注療法や免疫抑制剤の急速減量に伴い重症肺GVHDを発症した.NIMA相補的同胞からの移植後免疫療法の危険性が示唆された.
In the selection of alternative donors for stem cell transplantation (SCT), if an HLA full-match donor can not be secured, the identity of the most appropriate donor is unclear. We experienced two children with refractory, acute myeloblastic leukemia (AML) who underwent SCT from the non-inherited maternal antigen (NIMA) -mismatched sibling donor linked with long-term feto-maternal microchimerism, with expectation of graft-versusleukemia (GVL) effect. The engraftments were speedy and acute graft-versus-host disease (GVHD) did not occur. But after donor lymphocyte infusion (DLI) or acute tapering of their immunosuppressant, severe lung complication with GVHD occurred in both cases. Our cases suggest the risk of immunotherapy after SCT from a NIMA-mismatched sibling donor.
Author YOKOTA, Shumpei
YOKOSUKA, Tomoko
GOTO, Hiroaki
KUROKI, Fumiko
TAKAHASHI, Hiroyuki
FUJII, Hisaki
MINAI, Amane
YANAGIMACHI, Masakatsu
Author_FL 黒木 文子
横須賀 とも子
薬袋 周
柳町 昌克
横田 俊平
高橋 浩之
藤井 久紀
後藤 裕明
Author_FL_xml – sequence: 1
  fullname: 柳町 昌克
– sequence: 2
  fullname: 後藤 裕明
– sequence: 3
  fullname: 横須賀 とも子
– sequence: 4
  fullname: 薬袋 周
– sequence: 5
  fullname: 藤井 久紀
– sequence: 6
  fullname: 黒木 文子
– sequence: 7
  fullname: 高橋 浩之
– sequence: 8
  fullname: 横田 俊平
Author_xml – sequence: 1
  fullname: GOTO, Hiroaki
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: YOKOTA, Shumpei
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: YOKOSUKA, Tomoko
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: YANAGIMACHI, Masakatsu
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: FUJII, Hisaki
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: TAKAHASHI, Hiroyuki
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: KUROKI, Fumiko
  organization: Department of Pediatrics, Yokohama City University School of Medicine
– sequence: 1
  fullname: MINAI, Amane
  organization: Department of Pediatrics, Yokohama City University School of Medicine
BackLink https://cir.nii.ac.jp/crid/1390001204342977920$$DView record in CiNii
BookMark eNo9kbFu2zAQhokiBeqmmbve0KEd5PIoShRHQ2kTA3Y62O0qUCRl0ZBIg2Qb9Hn6onHgNMt_w3334YD_PbnywVtCPiJdInJkX4_H04iyEUvGlgzfkAU2DS-4YOUVWVCJZdEIWr8jNym5ntKqaSjlYkH-7R8DtCrZBGGAnf1jo4XNb3-ANsynyWmVXfCwSilop7I18OjyCHe_7m9BDdlG2GU7Q2unCfZR-XSalM-XoyGGGfJo4SH4Yu1HG92zYHvWRK8mWPnsDtbD54f1dvUFiq1Ls8p6PDM710_u_MRt8CF-IG8HNSV78zKvyc_v3_btfbH5cbduV5viiLymha5ZL1kjmGW6aowYKFKutKkrKfoKjdZK1j1iWXGpDTeDMZUZhK5oiQKFKK_Jp4vXO9dp95xYSkopMspLzqQQktEz1l6wY8rqYLtTdLOKfzsVs9OT7f5X0THW4Uvg61aPKnbWl0-bs4aT
ContentType Journal Article
Copyright Copyright Clearance Center, Inc
Copyright_xml – notice: Copyright Clearance Center, Inc
DBID RYH
DOI 10.11412/jjph1987.22.21
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate NIMA相補的ドナーからの移植後に致死的肺GVHDを合併した2例
DocumentTitle_FL NIMA相補的ドナーからの移植後に致死的肺GVHDを合併した2例
EISSN 1884-4723
EndPage 27
ExternalDocumentID 130004345966
article_jjph1987_22_1_22_1_21_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j1460-c62b92872e2c58d7f0104acd6597b51dcca96b113549cd4dfdd5df7c503171773
ISSN 0913-8706
IngestDate Thu Jun 26 22:27:42 EDT 2025
Wed Sep 03 06:30:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1460-c62b92872e2c58d7f0104acd6597b51dcca96b113549cd4dfdd5df7c503171773
OpenAccessLink https://www.jstage.jst.go.jp/article/jjph1987/22/1/22_1_21/_article/-char/en
PageCount 7
ParticipantIDs nii_cinii_1390001204342977920
jstage_primary_article_jjph1987_22_1_22_1_21_article_char_en
PublicationCentury 2000
PublicationDate 2008
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – year: 2008
  text: 2008
PublicationDecade 2000
PublicationTitle The Japanese Journal of Pediatric Hematology
PublicationTitleAlternate J.J.P.H.
PublicationTitle_FL 日本小児血液学会雑誌
J.J.P.H
日小血会誌
PublicationYear 2008
Publisher THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY
特定非営利活動法人 日本小児血液・がん学会
Publisher_xml – name: THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY
– name: 特定非営利活動法人 日本小児血液・がん学会
References 19) Ferster A, Bujan W, Mouraux T, et al : Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant 14 : 331-332, 1994
17) Or R, Hadar E, Bitan M, et al : Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation. Biol Blood Marrow Transplant 12 : 1295-1301, 2006
2) Yoshihara T, Okada K, Kobayashi M, et al : Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents. Int J Hematol 85 : 246-255, 2007
12) Huang XJ, Liu DH, Liu KY, et al : Donor lymphocyte infusion for the treatment of leukemia relapse after HLAmismatched/haploidentical T-cell-replete hematopoieticstem cell transplantation. Haematologica 92 : 414-417, 2007
9) Linus H, Tomas S, Fausto R, et al : Risk factors for bronchiolitis obliterans in allogenic hematopoietic stemcell transplantation for leukemia. Chest 128 : 153-161, 2005
1) 日本造血幹細胞移植学会平成17年度全国調査報告書 www.jshct.com/report_2005/index.html
11) Lacerda JF, Martins C, Carmo JA, et al : Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen. Biol Blood Marrow Transplant 9 : 633-642, 2003
8) Schultz KR, Green GJ, Wensley D, et al : Obstructive lung disease in children after allogenic bone marrow transplantation. Blood 84 : 3212-3220, 1994
13) 玉木茂久, 一戸辰夫, 内山卓, 他 : NIMA相補的血縁者間造血細胞移植に関する後方視的全国調査 (中間報告-2).厚生労働科学研究費補助金.ヒトゲノム・再生医療等研究事業総合・総括・分担研究報告書 (平成14年度) : 227, 2002
14) Pagano L, Offidani M, Fianchi L, et al : Mucormycosis in hematologic patients. Haematologica 89 : 207-214, 2004
5) Estey E, Thall P, Andreeff M, et al : Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes : Comparison with fludarabine plus cytarabine without granulocyte colonystimulating factor. J Clin Oncol 12 : 671-678, 1994
6) Yates B, Murphy DM, Forrest IA, et al : Azithromycin reverses airflow obstruction in established bronchiolitia obliterans syndrome. Am J Respir Crit Care Med 172 : 772-775, 2005
3) van Rood JJ, Loberiza FR, Jr, Zhang MJ, et al : Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 99 : 1572-1577, 2002
4) 丸屋悦子 : 母児免疫寛容と造血幹細胞移植.日本内科学会雑誌 94 : 1362-1368, 2005
7) Afessa B, Litzow MR, Tefferi A : Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplantation 28 : 425-434, 2001
10) Yoshihara S, Tateishi U, Ando T, et al : Lower incidence of bronchiolitis obliterans in allogenic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone marrow transplant 35 : 1195-1200, 2005
18) 塩原信太郎 : DLIの適応と方法.血液・腫瘍科 42 : 151-157, 2001
15) 大坂顯通, 大戸斉, 菊田敦, 他 : 安全な穎粒球輸血を目指したガイドライン案の作成.日本輸血学会雑誌 50 : 739-745, 2004
16) Ichinohe T, Uchiyama T, Shimazaki C, et al : Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA) -mismatched family members linked with longterm fetomaternal microchimerism. Blood 104 : 3821-3828, 2004
References_xml – reference: 10) Yoshihara S, Tateishi U, Ando T, et al : Lower incidence of bronchiolitis obliterans in allogenic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone marrow transplant 35 : 1195-1200, 2005
– reference: 3) van Rood JJ, Loberiza FR, Jr, Zhang MJ, et al : Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 99 : 1572-1577, 2002
– reference: 13) 玉木茂久, 一戸辰夫, 内山卓, 他 : NIMA相補的血縁者間造血細胞移植に関する後方視的全国調査 (中間報告-2).厚生労働科学研究費補助金.ヒトゲノム・再生医療等研究事業総合・総括・分担研究報告書 (平成14年度) : 227, 2002
– reference: 12) Huang XJ, Liu DH, Liu KY, et al : Donor lymphocyte infusion for the treatment of leukemia relapse after HLAmismatched/haploidentical T-cell-replete hematopoieticstem cell transplantation. Haematologica 92 : 414-417, 2007
– reference: 5) Estey E, Thall P, Andreeff M, et al : Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes : Comparison with fludarabine plus cytarabine without granulocyte colonystimulating factor. J Clin Oncol 12 : 671-678, 1994
– reference: 7) Afessa B, Litzow MR, Tefferi A : Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplantation 28 : 425-434, 2001
– reference: 6) Yates B, Murphy DM, Forrest IA, et al : Azithromycin reverses airflow obstruction in established bronchiolitia obliterans syndrome. Am J Respir Crit Care Med 172 : 772-775, 2005
– reference: 8) Schultz KR, Green GJ, Wensley D, et al : Obstructive lung disease in children after allogenic bone marrow transplantation. Blood 84 : 3212-3220, 1994
– reference: 4) 丸屋悦子 : 母児免疫寛容と造血幹細胞移植.日本内科学会雑誌 94 : 1362-1368, 2005
– reference: 16) Ichinohe T, Uchiyama T, Shimazaki C, et al : Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA) -mismatched family members linked with longterm fetomaternal microchimerism. Blood 104 : 3821-3828, 2004
– reference: 11) Lacerda JF, Martins C, Carmo JA, et al : Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen. Biol Blood Marrow Transplant 9 : 633-642, 2003
– reference: 14) Pagano L, Offidani M, Fianchi L, et al : Mucormycosis in hematologic patients. Haematologica 89 : 207-214, 2004
– reference: 15) 大坂顯通, 大戸斉, 菊田敦, 他 : 安全な穎粒球輸血を目指したガイドライン案の作成.日本輸血学会雑誌 50 : 739-745, 2004
– reference: 1) 日本造血幹細胞移植学会平成17年度全国調査報告書 www.jshct.com/report_2005/index.html
– reference: 2) Yoshihara T, Okada K, Kobayashi M, et al : Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents. Int J Hematol 85 : 246-255, 2007
– reference: 9) Linus H, Tomas S, Fausto R, et al : Risk factors for bronchiolitis obliterans in allogenic hematopoietic stemcell transplantation for leukemia. Chest 128 : 153-161, 2005
– reference: 19) Ferster A, Bujan W, Mouraux T, et al : Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant 14 : 331-332, 1994
– reference: 18) 塩原信太郎 : DLIの適応と方法.血液・腫瘍科 42 : 151-157, 2001
– reference: 17) Or R, Hadar E, Bitan M, et al : Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation. Biol Blood Marrow Transplant 12 : 1295-1301, 2006
SSID ssib005880047
ssj0003236711
ssib053390765
ssib002003923
ssib058493933
Score 1.7446932
Snippet In the selection of alternative donors for stem cell transplantation (SCT), if an HLA full-match donor can not be secured, the identity of the most appropriate...
SourceID nii
jstage
SourceType Publisher
StartPage 21
SubjectTerms acute tapering of immunosuppressant
donor lymphocyte infusion (DLI)
graft-versus-host disease
non-inherited maternal antigen (NIMA)
Title Two Cases of Severe Lung Complication Associated with GVHD after Stem Cell Transplantation from the Non-Inherited Maternal Antigen (NIMA) -Mismatched Sibling Donor
URI https://www.jstage.jst.go.jp/article/jjph1987/22/1/22_1_21/_article/-char/en
https://cir.nii.ac.jp/crid/1390001204342977920
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX The Japanese Journal of Pediatric Hematology, 2008/02/29, Vol.22(1), pp.21-27
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1884-4723
  dateEnd: 20081231
  omitProxy: true
  ssIdentifier: ssj0003236711
  issn: 0913-8706
  databaseCode: KQ8
  dateStart: 19870101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF615cIFgQBRoGgPHECRQ7x-rFfiYiWhSUuSQhxUTtb6pTqldpUmQuLv8EeZ2bUdh3KgcFlF2cSyPfPtfDs7D0Jey4jHwvMcI3IFM2ygsIZkiWOk0hISFFq6LiYKT6buaGGfnDvne_udVtTSZh114x9_zCv5F6nCdyBXzJK9g2Sbi8IX8BnkCyNIGMa_k_H3stMHM6TCMeYp3H_a-bipDvJrb1wjgTrQ_PjLaFD1Bp-v06tOH913usj5N1nU0Yd12sm0LIxxgVmCeIGJ1EWjsegA1vFUzXzGEx-dC8YkvwH-C1oAHDaPVJ77oCzKVZsAq1Q0MNDY-LLTYsNNyxAwhHCRHWf_8SyYKROZr0ogvM1CNTudBb5y316AUqY7E_PFqZoKyqvysmxmsH8B3G5_NNaJSjfyUq5175fG9-E1eorhUCf-mT8dzodYM2I8DL5imNTZcDD2g8-gwKPhxA_UWRxIcTbtb4_lKvenaRl4xqvtoF78Pc82bK7zn2vrwNgtFNRLfYs06PoGt82RbWJ92-Xy-gKdO13GuvXfdmp8VxoU1j8MGQvNajDDehbz8EDt98k9xoFWYQTCp9ZeEdOsW1zPgZW5daQKtF70-PZIG4insETF9ZG2WFjLT_Wrbt5NVQoLn-Ld7jMAX1vC7gXLUuwXed6iZMFD8qDSHurrG39E9pbyMfkJoKAKFLTMqAYFRVDQNijoFhQUQUERFFSBgiIoKIKC_gYKiqCgAAq6Awpag4JWoKBvEBJvaQsQtAIEVYB4QhYfhkF_ZFSdSIwlMImeEbssEszjLGWx4yU8Qy-GjBMXtuORYyawDAo3Mk3LsUWc2EmWJE6S8dgBk8lNzq2n5KAoi_QZoWbqZrEVYRFiaTvCFlEKY4xtlzIPWNAhea_fbHity82Ed1KOQ3IE8gjjHEfY3SlPc8-2gHZyLljv-f9d_gW5rwOm0Af5khysV5v0CFj5OnqltPEXLZrcSg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Two+Cases+of+Severe+Lung+Complication+Associated+with+GVHD+after+Stem+Cell+Transplantation+from+the+Non-Inherited+Maternal+Antigen+%28NIMA%29+-Mismatched+Sibling+Donor&rft.jtitle=The+Japanese+Journal+of+Pediatric+Hematology&rft.au=GOTO%2C+Hiroaki&rft.au=YOKOTA%2C+Shumpei&rft.au=YOKOSUKA%2C+Tomoko&rft.au=YANAGIMACHI%2C+Masakatsu&rft.date=2008&rft.pub=THE+JAPANESE+SOCIETY+OF+PEDIATRIC+HEMATOLOGY%2FONCOLOGY&rft.issn=0913-8706&rft.eissn=1884-4723&rft.volume=22&rft.issue=1&rft.spage=21&rft.epage=27&rft_id=info:doi/10.11412%2Fjjph1987.22.21&rft.externalDocID=article_jjph1987_22_1_22_1_21_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0913-8706&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0913-8706&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0913-8706&client=summon